Marijuana and Madness
David Castle, Robin M. Murray, Deepak Cyril D'Souza
Cambridge University Press, Oct 27, 2011 - Medical
The second edition of this critically acclaimed and award-winning text provides a comprehensive overview of the psychiatry and neuroscience of Cannabis sativa (marijuana). It outlines the very latest developments in our understanding of the human cannabinoid system, and links this knowledge to clinical and epidemiological facts about the impact of cannabis on mental health. Clinically focused chapters review not only the direct psychomimetic properties of cannabis, but also the impact consumption has on the courses of evolving or established mental illnesses such as schizophrenia. Effects of cannabis on mood are reviewed, as are its effects on cognition. This new edition has been extensively updated and expanded with ten new chapters to incorporate major new research findings. This book will be of interest to all members of the mental health team, as well as to neuroscientists, epidemiologists, public health specialists and those involved in drug and alcohol research.
What people are saying - Write a review
We haven't found any reviews in the usual places.
2 Other cannabinoids
3 The function of the endocannabinoid system
4 Is cannabis becoming more potent?
5 What are the policy implications of the evidence on cannabis and psychosis?
6 Cannabis endocannabinoids and neurodevelopment
7 The impact of pubertal exposure to cannabis on the brain a focus on animal studies
8 Cannabis and cognition short and longterm effects
13 Cannabinoids and the cerebellum a potential role in the development of psychosis
14 The neural basis for the acute effects of cannabis on learning and psychosis
15 Does cannabis use cause schizophrenia? The epidemiological evidence
16 Postmortem studies of the brain cannabinoid system in schizophrenia
17 The endocannabinoid system in schizophrenia
18 The acute effects of cannabinoids in patients with psychotic illness
19 Cannabis abuse and the course of schizophrenia
20 Understanding cannabis use in schizophrenia
Other editions - View all
2-arachidonoyl glycerol activation Addiction adolescent adult agonist alcohol alterations anandamide Arch Gen Psychiatry assessed association between cannabis baseline behavior bipolar disorder brain canna cannabidiol cannabinoid CB1 cannabinoid receptor cannabis abuse cannabis users causal CB1 receptor cerebellar cerebellum Chapter chronic clinical cognitive cohort comorbidity controls cortex cortical D’Souza David Castle decrease deficits Degenhardt depression dopamine drug effects of cannabis effects of THC endocannabinoid system endogenous cannabinoid etal evidence exposure factors follow-up function genetic Henquet herbal cannabis hippocampal human impaired increased inhibition inhibitory interaction levels long-term marijuana mean THC content Mechoulam mediated memory mental health mice nabis nederwiet neural neurons Neuropsychopharmacology Neurosci ofcannabis ofthe onset outcomes Pertwee Pharmacol potency Psychiatry psychosis psychotic disorders psychotic symptoms puberty Purkinje cells rats relationship between cannabis reported rimonabant risk role sample Schizophr schizophrenia schizophrenia patients schizotypy signaling sinsemilla Solowij studies substance synaptic tetrahydrocannabinol tion treatment